Virtus ETF Advisers LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$91,000
-48.3%
44,300
-5.6%
0.04%
-37.9%
Q4 2021$176,000
-28.2%
46,931
-0.9%
0.07%
-38.9%
Q3 2021$245,000
+15.6%
47,350
-5.0%
0.11%
+24.1%
Q2 2021$212,000
-45.5%
49,819
-32.0%
0.09%
-47.0%
Q1 2021$389,000
+0.3%
73,237
+1.8%
0.16%
+1.9%
Q4 2020$388,000
+57.1%
71,954
+132.0%
0.16%
+23.8%
Q3 2020$247,000
-30.0%
31,009
-12.0%
0.13%
-22.2%
Q2 2020$353,000
+61.9%
35,241
-30.4%
0.17%
-64.0%
Q1 2019$218,000
-34.9%
50,655
-13.0%
0.46%
+714.0%
Q4 2018$335,000
-34.3%
58,223
+54.8%
0.06%
+7.5%
Q3 2018$510,000
-34.1%
37,603
-42.3%
0.05%
-92.3%
Q2 2018$774,000
+307.4%
65,221
+141.8%
0.68%
+643.5%
Q3 2016$190,000
-13.6%
26,9740.0%0.09%
-43.6%
Q2 2016$220,000
-3.9%
26,974
-4.3%
0.16%
-48.3%
Q1 2016$229,00028,1820.32%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders